Search Results
An overview of novel treatment approaches in TP53-mutated AML
Novel non-transplant treatment approaches for high-risk TP53-mutated myeloid disease
Treatment of TP53-Mutated AML
Treatment approaches for patients with TP53-mutated MCL
Challenges in treating patients with TP53-mutated AML and future outlooks
Treatment options for patients with TP53-mutated AML
Progress in the treatment of TP53 mutated AML
Treatment approaches for patients with TP53m AML ineligible for high intensity chemotherapy
A Drug to Finally Benefit Patients with TP53 Mutant AML? | David Sallman | ASH 2021 #AML
Challenges in treating patients with TP53-mutated MCL & promising novel therapies being explored
Dr. Pemmaraju on the Challenges of Targeting TP53 Mutations in MDS/AML
Eprenetapopt plus venetoclax and azacitidine in the treatment of TP53-mutated AML
